Racial disparities in prostate cancer epidemiology and survival
outcomes generally have been well documented, with assorted facts and figures
indicating that African-American men are disadvantaged with regard to disease
control and therapeutic gains associated with this disease relative to their
Caucasian-American counterparts.
Prostate cancer is a daunting disease state for all
Americans: it represents the most commonly diagnosed malignancy and the second
most common cause of cancer-related deaths in the United States. However, for
African-American men, the public health implications of this disease are all
the more sobering: the disease incidence is 1.62-fold greater for
African-American men than for Caucasian-American men and the mortality
rate-ratio is 2.45-fold greater, respectively.
In blunt absolute terms, 1 in 3 African-American men will be
at risk for developing clinically significant prostate cancer and as much as 1
in 5 African-American men >50 years of age will die of this disease.
No comments:
Post a Comment